PeerVoice Heart & Lung Audio-logo

PeerVoice Heart & Lung Audio

Education Podcasts

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Location:

United States

Description:

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Language:

English


Episodes

GnRH Antagonist vs LHRH Agonist: To Desensitize or To Inhibit, That Is the Question!

2/17/2021
GnRH Antagonist vs LHRH Agonist: To Desensitize or To Inhibit, That Is the Question!

Duration:00:19:13

Stroke Prevention, Type 2 Diabetes, and GLP-1 Receptor Agonists: What Neurologists Need to Know

2/3/2021
Stroke Prevention, Type 2 Diabetes, and GLP-1 Receptor Agonists: What Neurologists Need to Know

Duration:00:44:47

Modern Management of Chronic Kidney Disease: A Look to the Future

1/20/2021
Modern Management of Chronic Kidney Disease: A Look to the Future

Duration:00:10:32

Cardiovascular Risk and Prostate Cancer: Clinical Perspectives on ADT

1/15/2021
Cardiovascular Risk and Prostate Cancer: Clinical Perspectives on ADT

Duration:00:22:24

Simplifying Fluid Therapy: Critical Care for the Critically Ill

1/11/2021
Simplifying Fluid Therapy: Critical Care for the Critically Ill

Duration:00:17:10

SGLT2 Inhibition for HF: Evidence From Virtual Scientific Sessions 2020

1/8/2021
SGLT2 Inhibition for HF: Evidence From Virtual Scientific Sessions 2020

Duration:00:37:42

A Look at Emerging SMA Outcomes: Highlights of WMS 2020

1/7/2021
A Look at Emerging SMA Outcomes: Highlights of WMS 2020

Duration:00:09:11

Managing Risk of Persistent Acute Kidney Injury in the ICU: The RUBY Study

12/30/2020
Managing Risk of Persistent Acute Kidney Injury in the ICU: The RUBY Study

Duration:00:19:36

PARPs in Practice in mCRPC: A Look at the Latest Data

12/18/2020
PARPs in Practice in mCRPC: A Look at the Latest Data

Duration:00:17:07

Treatment Update in Type 2 Diabetes: What’s New, and What Does It Mean for Patients?

12/16/2020
Treatment Update in Type 2 Diabetes: What’s New, and What Does It Mean for Patients?

Duration:00:15:42

Modern Management of Chronic Kidney Disease: A Look to the Future

11/11/2020
Modern Management of Chronic Kidney Disease: A Look to the Future

Duration:00:15:03

Practice Challenges in Advanced EGFR-Mutant NSCLC: Clarifying First-Line Strategies

11/9/2020
Practice Challenges in Advanced EGFR-Mutant NSCLC: Clarifying First-Line Strategies

Duration:00:25:11

Transforming Management of Early-Stage EGFR-Mutant NSCLC: Insights From the Latest Data

11/3/2020
Transforming Management of Early-Stage EGFR-Mutant NSCLC: Insights From the Latest Data

Duration:00:18:48

Defining Control in Moderate-to-Severe Asthma: Where Are We Now and What Can We Do?

10/30/2020
Defining Control in Moderate-to-Severe Asthma: Where Are We Now and What Can We Do?

Duration:00:18:39

Best Practices for MET Mutation Testing in NSCLC: The Role of the Oncologist and the Pathologist

10/25/2020
Best Practices for MET Mutation Testing in NSCLC: The Role of the Oncologist and the Pathologist

Duration:00:16:37

New Targets in Heart Failure: Congress Updates on SGLT2 Inhibitors

10/21/2020
New Targets in Heart Failure: Congress Updates on SGLT2 Inhibitors

Duration:00:12:31

Halting the Cascade of Chronic Kidney Disease: Can We Catch Patients Before They Fall?

10/15/2020
Halting the Cascade of Chronic Kidney Disease: Can We Catch Patients Before They Fall?

Duration:00:36:02

A Look at Emerging SMA Outcomes: Highlights of CureSMA 2020

10/5/2020
A Look at Emerging SMA Outcomes: Highlights of CureSMA 2020

Duration:00:09:55

A Look at Emerging SMA Outcomes: Highlights of EAN 2020

10/2/2020
A Look at Emerging SMA Outcomes: Highlights of EAN 2020

Duration:00:09:51

Deciphering the Role of MET Alterations in Advanced NSCLC: Unmet Needs

9/28/2020
Deciphering the Role of MET Alterations in Advanced NSCLC: Unmet Needs

Duration:00:15:43